Pfizer, Allergan Say FTC Seeking More Info On Inversion Deal
By Kurt Orzeck · March 30, 2016, 8:05 PM EDT
The U.S. Federal Trade Commission is asking Pfizer Inc. and Allergan PLC for more information regarding their proposed merger, which would mark the largest tax inversion deal ever recorded and was...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login